INDIAN BENCHMARKS at day's high …Banks lead gains.
INDIAN BENCHMARKS ended by trading at the highs of the day, bolstered by strength on the banking counters. DLF rose 1.96% after the company issued a clarification with regard to penalty charged against it by the Competition Commission of India.
Further, Lupin received final approval for its Pioglitazone Tablets USP from the United States Food and Drugs Administration to market a generic version of Takeda Actos Tablets. Shares of Sun Pharma and Ranbaxy gained by 6.75% and 4.6% respectively after Sun Pharma Chairman Israel Makov said that there was no insider trading a day after it announced its US$4bn proposal to merge Ranbaxy with itself.
The crucial resistance for Nifty is now seen at 6830 and above this 6870. Support for the immediate term is now placed at 6700 and next support will be 6670.
For More Detail Call Us 0731-6790000,6669900
Click Here capitalstars.com 
0 Comments